node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
Apt1 | CG2818 | FBpp0303935 | FBpp0077226 | Uncharacterized protein, isoform E; Carboxylic ester hydrolase activity; palmitoyl-(protein) hydrolase activity. It is involved in the biological process described with: protein depalmitoylation. | LD22655p; Glycerophosphocholine phosphodiesterase activity; starch binding. It is involved in the biological process described with: glycerophospholipid catabolic process. | 0.905 |
Apt1 | sws | FBpp0303935 | FBpp0071077 | Uncharacterized protein, isoform E; Carboxylic ester hydrolase activity; palmitoyl-(protein) hydrolase activity. It is involved in the biological process described with: protein depalmitoylation. | Neuropathy target esterase sws; Phospholipase B that deacylates intracellular phosphatidylcholine (PtdCho), generating glycerophosphocholine (GroPtdCho). This deacylation occurs at both sn-2 and sn-1 positions of PtdCho. Its specific chemical modification by certain organophosphorus (OP) compounds leads to distal axonopathy. Plays a role in the signaling mechanism between neurons and glia that regulates glia wrapping during development of the adult brain. Essential for membrane lipid homeostasis and cell survival in both neurons and glia of the adult brain; Belongs to the NTE family. | 0.902 |
CG14507 | CG18858 | FBpp0112217 | FBpp0305187 | Calcium ion binding; phospholipase A2 activity. It is involved in the biological process described with: arachidonic acid secretion; phospholipid metabolic process; lipid catabolic process. | Uncharacterized protein, isoform A; O-acyltransferase activity. It is involved in the biological process described with: lipid metabolic process. | 0.675 |
CG14507 | CG3009 | FBpp0112217 | FBpp0070656 | Calcium ion binding; phospholipase A2 activity. It is involved in the biological process described with: arachidonic acid secretion; phospholipid metabolic process; lipid catabolic process. | RH14732p; Calcium-dependent phospholipase A2 activity. It is involved in the biological process described with: arachidonic acid secretion; phospholipid metabolic process. | 0.904 |
CG14507 | CG31683 | FBpp0112217 | FBpp0080897 | Calcium ion binding; phospholipase A2 activity. It is involved in the biological process described with: arachidonic acid secretion; phospholipid metabolic process; lipid catabolic process. | BcDNA.GH02384; O-acyltransferase activity. It is involved in the biological process described with: lipid metabolic process. | 0.675 |
CG14507 | LPCAT | FBpp0112217 | FBpp0110147 | Calcium ion binding; phospholipase A2 activity. It is involved in the biological process described with: arachidonic acid secretion; phospholipid metabolic process; lipid catabolic process. | Lysophosphatidylcholine acyltransferase; Acetyltransferase which mediates the conversion of 1-acyl-sn- glycero-3-phosphocholine (LPC) into phosphatidylcholine (PC) (By similarity). Has a calcium-independent activity (By similarity). Displays a clear preference for saturated fatty acyl-CoAs, and 1- myristoyl or 1-palmitoyl LPC as acyl donors and acceptors, respectively (By similarity). Involved in the regulation of lipid droplet number and size. | 0.909 |
CG14507 | iPLA2-VIA | FBpp0112217 | FBpp0076093 | Calcium ion binding; phospholipase A2 activity. It is involved in the biological process described with: arachidonic acid secretion; phospholipid metabolic process; lipid catabolic process. | Calcium-independent phospholipase A2 VIA (iPLA2-VIA) encodes a protein that localizes to cytosol and mitochondria involved in repairing oxidized mitochondrial lipids, such as cardiolipin, and thus preventing cytochrome c release. It is partially responsible for cardiolipin depletion and monolysocardiolipin accumulation in Taz-deficient flies, which is a model of Barth syndrome. | 0.969 |
CG14507 | sPLA2 | FBpp0112217 | FBpp0099486 | Calcium ion binding; phospholipase A2 activity. It is involved in the biological process described with: arachidonic acid secretion; phospholipid metabolic process; lipid catabolic process. | Secretory phospholipase A2, isoform A; Calcium-dependent phospholipase A2 activity. It is involved in the biological process described with: arachidonic acid secretion; phospholipid metabolic process. | 0.919 |
CG14507 | sws | FBpp0112217 | FBpp0071077 | Calcium ion binding; phospholipase A2 activity. It is involved in the biological process described with: arachidonic acid secretion; phospholipid metabolic process; lipid catabolic process. | Neuropathy target esterase sws; Phospholipase B that deacylates intracellular phosphatidylcholine (PtdCho), generating glycerophosphocholine (GroPtdCho). This deacylation occurs at both sn-2 and sn-1 positions of PtdCho. Its specific chemical modification by certain organophosphorus (OP) compounds leads to distal axonopathy. Plays a role in the signaling mechanism between neurons and glia that regulates glia wrapping during development of the adult brain. Essential for membrane lipid homeostasis and cell survival in both neurons and glia of the adult brain; Belongs to the NTE family. | 0.903 |
CG18858 | CG14507 | FBpp0305187 | FBpp0112217 | Uncharacterized protein, isoform A; O-acyltransferase activity. It is involved in the biological process described with: lipid metabolic process. | Calcium ion binding; phospholipase A2 activity. It is involved in the biological process described with: arachidonic acid secretion; phospholipid metabolic process; lipid catabolic process. | 0.675 |
CG18858 | CG2818 | FBpp0305187 | FBpp0077226 | Uncharacterized protein, isoform A; O-acyltransferase activity. It is involved in the biological process described with: lipid metabolic process. | LD22655p; Glycerophosphocholine phosphodiesterase activity; starch binding. It is involved in the biological process described with: glycerophospholipid catabolic process. | 0.900 |
CG18858 | CG3009 | FBpp0305187 | FBpp0070656 | Uncharacterized protein, isoform A; O-acyltransferase activity. It is involved in the biological process described with: lipid metabolic process. | RH14732p; Calcium-dependent phospholipase A2 activity. It is involved in the biological process described with: arachidonic acid secretion; phospholipid metabolic process. | 0.692 |
CG18858 | CG31683 | FBpp0305187 | FBpp0080897 | Uncharacterized protein, isoform A; O-acyltransferase activity. It is involved in the biological process described with: lipid metabolic process. | BcDNA.GH02384; O-acyltransferase activity. It is involved in the biological process described with: lipid metabolic process. | 0.900 |
CG18858 | LPCAT | FBpp0305187 | FBpp0110147 | Uncharacterized protein, isoform A; O-acyltransferase activity. It is involved in the biological process described with: lipid metabolic process. | Lysophosphatidylcholine acyltransferase; Acetyltransferase which mediates the conversion of 1-acyl-sn- glycero-3-phosphocholine (LPC) into phosphatidylcholine (PC) (By similarity). Has a calcium-independent activity (By similarity). Displays a clear preference for saturated fatty acyl-CoAs, and 1- myristoyl or 1-palmitoyl LPC as acyl donors and acceptors, respectively (By similarity). Involved in the regulation of lipid droplet number and size. | 0.915 |
CG18858 | iPLA2-VIA | FBpp0305187 | FBpp0076093 | Uncharacterized protein, isoform A; O-acyltransferase activity. It is involved in the biological process described with: lipid metabolic process. | Calcium-independent phospholipase A2 VIA (iPLA2-VIA) encodes a protein that localizes to cytosol and mitochondria involved in repairing oxidized mitochondrial lipids, such as cardiolipin, and thus preventing cytochrome c release. It is partially responsible for cardiolipin depletion and monolysocardiolipin accumulation in Taz-deficient flies, which is a model of Barth syndrome. | 0.726 |
CG18858 | nes | FBpp0305187 | FBpp0074786 | Uncharacterized protein, isoform A; O-acyltransferase activity. It is involved in the biological process described with: lipid metabolic process. | Lysophospholipid acyltransferase 5; Acyltransferase which mediates the conversion of lysophosphatidylcholine (1-acyl-sn-glycero-3-phosphocholine or LPC) to phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine or PC) (LPCAT activity). May also catalyze the conversion of lysophosphatidylethanolamine (1-acyl-2-hydroxy-sn-glycero-3- phosphoethanolamine or LPE) to phosphatidylethanolamine (1,2-diacyl-sn- glycero-3-phosphoethanolamine or PE) (LPEAT activity), as well as the conversion of lysophosphatidylserine (1-acyl-2-hydroxy-sn-glycero-3- phospho-L-serine or LPS) to phosphatidylser [...] | 0.900 |
CG18858 | sPLA2 | FBpp0305187 | FBpp0099486 | Uncharacterized protein, isoform A; O-acyltransferase activity. It is involved in the biological process described with: lipid metabolic process. | Secretory phospholipase A2, isoform A; Calcium-dependent phospholipase A2 activity. It is involved in the biological process described with: arachidonic acid secretion; phospholipid metabolic process. | 0.692 |
CG18858 | sws | FBpp0305187 | FBpp0071077 | Uncharacterized protein, isoform A; O-acyltransferase activity. It is involved in the biological process described with: lipid metabolic process. | Neuropathy target esterase sws; Phospholipase B that deacylates intracellular phosphatidylcholine (PtdCho), generating glycerophosphocholine (GroPtdCho). This deacylation occurs at both sn-2 and sn-1 positions of PtdCho. Its specific chemical modification by certain organophosphorus (OP) compounds leads to distal axonopathy. Plays a role in the signaling mechanism between neurons and glia that regulates glia wrapping during development of the adult brain. Essential for membrane lipid homeostasis and cell survival in both neurons and glia of the adult brain; Belongs to the NTE family. | 0.927 |
CG2818 | Apt1 | FBpp0077226 | FBpp0303935 | LD22655p; Glycerophosphocholine phosphodiesterase activity; starch binding. It is involved in the biological process described with: glycerophospholipid catabolic process. | Uncharacterized protein, isoform E; Carboxylic ester hydrolase activity; palmitoyl-(protein) hydrolase activity. It is involved in the biological process described with: protein depalmitoylation. | 0.905 |
CG2818 | CG18858 | FBpp0077226 | FBpp0305187 | LD22655p; Glycerophosphocholine phosphodiesterase activity; starch binding. It is involved in the biological process described with: glycerophospholipid catabolic process. | Uncharacterized protein, isoform A; O-acyltransferase activity. It is involved in the biological process described with: lipid metabolic process. | 0.900 |